CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 60 enrolled
Drug / intervention
lyophilized black raspberry confection +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01823562
NCT01823562Phase 1Completed

Dietary Fruit Bioactives and Prostate Cancer

Ohio State University Comprehensive Cancer Center·interventional·Posted Apr 4, 2013·Updated May 20, 2026

In Brief

A Phase 1 clinical trial evaluating lyophilized black raspberry confection, laboratory biomarker analysis, and 3 other interventions for Stage I Prostate Cancer and 3 related conditions. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This Phase I/Ib trial is studying the absorption and metabolism of phytochemicals found in black raspberries in men undergoing surgery for prostate cancer. This knowledge will help us design future chemoprevention studies and assist in making future dietary recommendations for men at high risk for prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 4, 2013
Enrollment StartOct 17, 2012
Primary CompletionAug 1, 2013
Study CompletionNov 12, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.2 years ago

Interventions

lyophilized black raspberry confectiondrug

Given PO

laboratory biomarker analysisother

Correlative studies

dietary interventiondietary

Follow a low polyphenol diet

dietary interventiondietary

Follow a low ellagitannin diet

quality-of-life assessmentprocedure

Ancillary studies

questionnaire administrationother

Ancillary studies